drugset / Trial / NCT06232863
A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the safety and tolerability and pharmacokinetics of BH009 in patients with advanced head and neck squamous (non-nasopharyngeal) and ovarian cancer.
Timeline
- Start
- 2023-01-18
- Primary completion
- 2024-03-30
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BH009 | Unknown | — | — |